HOLX

Hologic
D

HOLX

67.840
USD
-0.23
(-0.33%)
مغلق
حجم التداول
75,610
الربح لكل سهم
4
العائد الربحي
-
P/E
28
حجم السوق
15,088,924,091
أصول ذات صلة
ABT
ABT
2.460
(1.90%)
131.760 USD
BDX
BDX
0.920
(0.47%)
195.920 USD
DGX
DGX
1.360
(0.76%)
179.800 USD
ISRG
ISRG
3.29
(0.69%)
480.08 USD
R
RGEN
-2.350
(-1.86%)
124.320 USD
SYK
SYK
3.31
(0.87%)
381.81 USD
T
TDOC
0.23000
(3.15%)
7.52500 USD
TMO
TMO
4.05
(0.83%)
489.18 USD
المزيد
الأخبار المقالات

العنوان: Hologic

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.